绿叶生物盘中跌超5% 附属发行可交换优先股 可换博安生物1亿股

Core Viewpoint - Luye Pharma's subsidiary, Luye Geneora, has issued exchangeable preferred shares worth approximately $150 million, which can be exchanged for up to 100 million shares of Boan Biologics, potentially affecting its subsidiary status [1] Group 1: Company Actions - Luye Geneora issued 4.75% exchangeable preferred shares to Bluebell Asset [1] - The funds raised will be used for general operational purposes of the group [1] Group 2: Market Reaction - Following the announcement, Luye Pharma's stock fell by 3.58% to HKD 2.96 [1] - Boan Biologics' stock also declined by 2.92% to HKD 10.63 [1] Group 3: Potential Impact - If all preferred shares are exchanged, Boan Biologics will no longer be a subsidiary of Luye Pharma [1]